219814-90-1

Basic information

• Product Name: ethyl 1,6-dimethyl-2-oxo-4-(2-thienyl)-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate
• Synonyms: ethyl 1,6-dimethyl-2-oxo-4-(2-thienyl)-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate
• CAS NO: 219814-90-1
• Molecular Formula: C13H16N2O3S
• Molecular Weight: 280.34274
• Mol File: 219814-90-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 1,6-dimethyl-2-oxo-4-(2-thienyl)-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 1,6-dimethyl-2-oxo-4-(2-thienyl)-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate(219814-90-1)
• EPA Substance Registry System: ethyl 1,6-dimethyl-2-oxo-4-(2-thienyl)-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate(219814-90-1)

Safety Data

• Hazardous Substances Data: 219814-90-1(Hazardous Substances Data)

Upstream product

• 2786-07-4 2-thienyl lithium 
• 930288-11-2 1,6-dimethyl-2-oxo-1,2-dihydropyrimidine-5-carboxylic acid ethyl ester 
• 188290-36-0 thiophene 
• 98-03-3 thiophene-2-carbaldehyde 
• 141-97-9 ethyl acetoacetate 
• 598-50-5 N-Methylurea 
• 636-72-6 2-thiophenemethanol 

Relevant articles and documents

Discovery of 3,4-dihydropyrimidin-2(1 H)-ones as a novel class of potent and selective A2B adenosine receptor antagonists

We describe the discovery and optimization of 3,4-dihydropyrimidin-2(1H)- ones as a novel family of (nonxanthine) A2B receptor antagonists that exhibit an unusually high selectivity profile. The Biginelli-based hit optimization process enabled a thoughtful exploration of the structure-activity and structure-selectivity relationships for this chemotype, enabling the identification of ligands that combine structural simplicity with excellent hA2B AdoR affinity and remarkable selectivity profiles.

3,4-Dihydropyrimidin-2(1 H)-ones as Antagonists of the Human A2BAdenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition

We present and thoroughly characterize a large collection of 3,4-dihydropyrimidin-2(1H)-ones as A2BAR antagonists, an emerging strategy in cancer (immuno) therapy. Most compounds selectively bind A2BAR, with a number of potent and selective antagonists fu

Solvent-Free Ball-Milling Biginelli Reaction by Subcomponent Synthesis

We report here an understanding of systems chemistry on small molecules through covalent mechanochemistry. As a proof-of-concept, the multicomponent Biginelli reaction by subcomponent synthesis was considered as a model system. Reactions were performed un

An efficacious protocol for 4-substituted 3,4-dihydropyrimidinones: Synthesis and calcium channel binding studies

Ethyl 1,2-dihydro-l, 6-dimethyl/6-methyl-2-oxopyrimidine-5carboxylates react with C-nucleophiles as well as the anion of the enantiopure chiral auxiliary (l R, 2 S,5 R) - (-) - methyl (S)p-toluenesulfinate to afford 4-substituted and enantiopure congeners

A highly regio- and chemoselective addition of carbon nucleophiles to pyrimidinones. A new route to C4 elaborated Biginelli compounds

Ethyl 6-methyl-pyrimidine-2-one-5-carboxylates react with C-nucleophiles in a diversity oriented synthetic sequence to afford C4 substituted congeners of medicinally potent Biginelli dihydropyrimidinones, in a highly regioselective manner.